The Lochmüller Lab wins CIHR project award!

We are delighted to announce that our project on congenital myasthenic syndromes (CMS) has been funded in the Canadian Institute for Health Research’s Fall 2018 project grant competition. Through this…

Read More

GNE myopathy

…and validation of biomarkers for GNE myopathy. In the clinical research area, Hanns has been principal investigator for several natural history and treatment studies in collaboration with the pharma company…

Read More

Collaborations

investigator at the CHEO Research Institute. He directs the care of children with neuromuscular disease from a large region of Eastern Ontario and Western Quebec and is principal investigator for

Read More

Meet the Lochmüller Lab Clinical Team

information system implementation (Project Fusion) for The Ottawa Hospital and Atlas Alliance hospitals, focusing on launching the Epic research module for Coordinators and Clinicians at the Ottawa Hospital Research Institute….

Read More

Matthew MacDonald

Matthew joined the team in June 2021 as a Research Coordinator, working on several neuromuscular disease clinical trials for Dr. Lochmüller….

Read More

Congenital myasthenic syndromes

Microscopy image of a neuromuscular junction

…of acetylcholine available in the synaptic cleft (for which commonly administered therapies include AChE inhibitors such as pyridostigmine, which inhibits acetylcholine breakdown, and the potassium-channel blocker 3,4-diaminopyridine, which increases the…

Read More

Marc-Olivier Deguise

Marc-Olivier Deguise

Marc-Olivier Deguise is currently a pediatric resident physician at Children’s Hospital of Eastern Ontario and has been involved with the SMA community through a research lens for the past eight…

Read More